Jason Stutman has been teasing the opportunity to invest in a small biotech company that could lead to “the end of aging”… or so he thinks. This company makes senolytic compounds, which I’ll talk more about, and right now it’s being teased as a “tiny $5 stock” that could turn an initial $500 investment into $1.5

Read More